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OUTBREAK OF HISTOPLASMOSIS AMONG CAVERS ATTENDING THE NATIONAL
SPELEOLOGICAL SOCIETY ANNUAL CONVENTION, TEXAS, 1994
DAVID A. ASHFORD, RANA A. HAJJEH, MICHAEL F. KELLEY, LEO KAUFMAN, LORI HUTWAGNER,
AND MICHAEL M. McNEIL
Meningitis and Special Pathogens Branch, Division of Bacterial and Mycotic Diseases, National Center for Infectious Diseases,
Centers for Disease Control and Prevention, Atlanta, Georgia; Communicable Disease Control, Texas Department of Health,
Austin, Texas

Abstract. In June 1994, 18 people developed serologically confirmed histoplasmosis following cave exploration
associated with the annual National Speleological Society Convention in Bracketville, Texas. Six others had an
undiagnosed illness suspected to be histoplasmosis. Two persons were hospitalized. We conducted a survey of convention attendees and a nested case-control study of those entering caves. We also conducted a histoplasmin skin test
survey of a subgroup of the society, the Texas Cavers Association, who were attending a reunion in October 1994.
Among the national convention attendees, exposure to two caves was identified as responsible for 22 (92%) of the
24 cases; 12 (75%) of 16 people exploring one cave (Cave A) and 10 (77%) of 13 exploring a separate cave (Cave
B) developed acute histoplasmosis. Additional risk-factors included fewer years of caving experience, longer time
spent in the caves, and entering a confined crawl space in Cave A. Of 113 participants in the separate skin test
survey, 68 (60%) were found to be skin test positive, indicating previous exposure to Histoplasma capsulatum. A
positive skin test was significantly associated with male sex and more years of caving experience. Those less experienced in caving associations should be taught about histoplasmosis, and health care providers should pursue histories
of cave exposure for patients with bronchitis or pneumonia that does not respond to initial antibiotic therapy.
Histoplasmosis is caused by Histoplasma capsulatum, a
dimorphic fungus that grows in soil. In the United States,
the Mississippi and Ohio River Valleys are considered areas
where H. capsulatum is endemic. In 1981, before the epidemic of acquired immunodeficiency syndrome (AIDS), it
was estimated that 50,000–200,000 cases occur annually in
the United States and of those, 500 were severe disseminated
infections.1 However, most infections go undiagnosed, since
patients usually recover without medical attention.1
The infection results primarily from inhalation of aerosolized spores from soil. Histoplasmosis (once referred to as
cave disease) can be acquired by occupational or recreational
exposure to environmental sources, usually in areas with endemic histoplasmosis. Caves represent one of the foci that
favor the propagation of the fungus,2,3 and bat-inhabited
caves may harbor H. capsulatum even in areas where histoplasmosis is of low endemicity.4
The significance of bird and bat droppings in the ecology
of histoplasmosis, through enhancing conditions for H. capsulatum growth, has been described.5–12 In addition to improving soil conditions with guano, bats contribute to propagation of H. capsulatum by transmitting the organism to
new sites.10,11,13 This is because the gastrointestinal tracts of
bats can be colonized with H. capsulatum.13 Unlike bats and
other mammals, avian species do not harbor the fungus, possibly because their core temperatures are too high.
Although caving has been shown to be associated with
exposure to H. capsulatum, review of the literature suggests
that cave-associated epidemics are uncommon or not recognized,4 and little is known about infection rates associated
with this activity. There are an estimated 50,000 cavers in
the United States (Luckins R, President, National Speleological Society, unpublished data).
From June 19 to 26, 1994 approximately 620 members of
the National Speleological Society attended their annual convention in Brackettville, Texas. Convention participants
camped out-of-doors and were involved in workshops and

daily excursions for cave exploration. During the convention, excursions were organized for 19 different caves. During the last two weeks of July, four convention attendees
developed headache, fever, cough, myalgia, severe fatigue,
and chest pain. Two persons were hospitalized for more than
one week; they were suspected to have acute pulmonary
histoplasmosis and they responded to antifungal therapy. Serum specimens from the four patients were tested by the
complement fixation (CF) and immunodiffusion (ID) assays
at CDC and found positive for antibodies to H. capsulatum.14
Biopsy specimens were not available for analysis.
The objectives of our investigation were to determine the
rates of clinically apparent infection among convention attendees, assess the extent of associated morbidity, determine
which caves were associated with infection, define risk factors associated with infection (including caves visited, activities in caves, environmental exposure, age, sex, race, occupation, and predisposing medical conditions) among those
entering suspect caves, and estimate the prevalence of H.
capsulatum infection in a subgroup of cavers.
To determine the size of the outbreak and to identify risk
factors for infection, we conducted a case-finding survey of
National Speleological Society members, a case-control
study of convention participants, and a cohort study of cavers entering high-risk caves. In addition, because little is
known about the prevalence of infection among what is considered to be a high-risk group, we conducted a separate
study to estimate the prevalence of histoplasmosis among
cavers attending a reunion of the Texas Cavers’ Association,
a subpopulation of the society.
METHODS

Case definition. For the purposes of this investigation, a
confirmed case of acute histoplasmosis was defined as onset
of illness between June 28 and July 30, 1994 and a positive
serology for H. capsulatum infection (CF titer greater than

899

900

ASHFORD AND OTHERS

1:32 or the presence of M bands in ID test) in a caver who
attended the convention. When sera were not available, a
suspected case was defined as a caver who attended the convention and had onset of illness between June 28 and July
30, 1994, and fever, chills, headache, cough, and two of the
following symptoms: fatigue, sweats, myalgias, or chest
pain.
Case finding. By distributing the questionnaire in the society’s monthly news publication, we conducted a survey of
convention attendees to identify additional cases of histoplasmosis. The questionnaire included questions regarding
attendance of the convention in Brackettville, demographic
variables, caves entered during the convention, time spent
caving, symptoms, treatment, underlying illness, current
therapies, and outcome. Serum was obtained from persons
who were suspected cases. Each participant, or a physician
he/she designated, was notified of serologic results and was
provided information about symptoms and management of
histoplasmosis. Informed consent was obtained from participants in this study, and the guidelines for human experimentation of the U.S. Department of Health and Human Services were followed.
Case-control study. To determine which of 19 caves visited during the convention were associated with infection,
we conducted a nested case-control study using responses to
the survey of convention participants. Two controls per casepatient were chosen randomly from 221 respondents who
attended the convention, entered caves, but did not develop
illness. Patients and controls were compared regarding
which caves were visited during the convention.
Cohort study. Twenty-nine convention participants who
entered the two caves (Cave A or Cave B) associated with
infection were evaluated for risk factors for histoplasmosis,
including age, years of caving experience, pre-existing illness, and specific activities in the caves (e.g., rappeling [sliding down a rope]).
Histoplasmin skin test survey. In a separate study, we
conducted a survey at the annual reunion of the Texas
Caver’s Association that was held October 21–23, 1994. After obtaining informed consent, we administered a questionnaire to 113 participants and applied a histoplasmin skin test.
Histoplasmin (Parke-Davis Laboratories, Detroit, MI) and
spherulin (ALK Laboratories, Berkeley, CA) as a control,
were applied intradermally to all meeting attendees who
agreed to be tested and were read 30–48 hr later by the same
observer. A blood specimen was also obtained from all consenting participants. A skin test was considered positive if
induration $ 5 mm was present.
Laboratory assays. Blood samples were allowed to clot
for 2–6 hr, and serum was separated, frozen, and shipped to
CDC for testing. Serum specimens were tested for antibodies
to H. capsulatum by both CF tests with histoplasmin and
yeast-form antigens and by ID with histoplasmin. Complement fixation titers $ 1:32 and the detection of M or both
M and H bands with the ID assay were considered presumptive evidence of acute infection with H. capsulatum.14
In the ID assay, the presence of M or H precipitation bands
indicates the presence of specific antibodies to H. capsulatum in case-patient sera.
Statistical methods. To evaluate differences in the potential risk factors, univariate analysis was done using chi-

FIGURE 1. Epidemic curve of acute histoplasmosis cases following the National Speleological Society Convention in Bracketville,
Texas, June 18–26, 1994.

square. To identify independent associations, multivariate
analysis was done using logistic regression including those
variables that were significant in the univariate analysis and
potential confounding variables.
RESULTS

Case finding. Two hundred twenty-one (36%) of the 620
convention participants responded to the mailed survey. In
addition to the initial four cases, 14 confirmed and six suspect cases were detected resulting in 18 of 24 suspect cases
being confirmed by serology. A histogram of the outbreak
is shown in Figure 1. Twenty-two (92%) of the 24 casepatients had explored one of two caves, referred to as Caves
A and B. None of those people entering Cave A entered
Cave B and vice-versa. Each of the groups entering Cave A
and Cave B had a team leader. From these team leaders and
team participants, complete lists of those who entered Cave
A or Cave B were generated. Sixteen people entered Cave
A and 13 people entered Cave B. Twelve of 16 attendees
entering Cave A and 10 of 13 exploring Cave B developed
histoplasmosis, giving cave-specific attack-rates of 75% and
71%, respectively. The range of incubation periods, from
cave exposure to onset of symptoms, was 10–14 days for
symptomatic participants. All case patients were previously
healthy, and reported not having entered other caves in the
one month before the National Speleological Society convention. All patients exhibited fever, chills, headache, and
cough of at least two-weeks duration. Cough and fatigue
persisted for 12 weeks in three patients. Eighteen of the 24
case-patients sought medical attention as a result of their
illness; of these, the mean time to diagnosis after first seeking medical attention was three weeks. Bacterial bronchitis
or pneumonia was the most common initial diagnosis. Sixteen (89%) of the 18 patients who sought medical attention
were treated with antibacterial therapy.
Case-control study. Of 19 caves entered during convention activities, two caves were significantly associated with
acute histoplasmosis: Cave A (odds ratio [OR] 5 13.3, 95%
confidence interval [CI] 5 3.2–60.2) and Cave B (OR 5
12.9, 95% CI 5 2.7–69.2).
Cohort study. Table 1 shows the analysis of risk factors
among those cavers entering Cave A or Cave B. Among the
cohort of those people entering the high risk-caves, younger
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TABLE 1
Risk factors* associated with histoplasmosis among cavers who entered Cave A or Cave B by univariate analysis†
Variable

Male sex (%)
Mean age (range)
Smoke (%)
Years caving, mean (range)
History of histoplasmosis (%)
Hours in cave, mean (range)
Rappeled in cave (%)
Saw bats (%)
Touched guano (%)
In Cave A only (12 cases, 4 non-cases)
entered long tunnel‡ (%)

Cases
(n 5 22)

15
29
3
10
2
5.16
13
21
21
11

(68)
(18–43)
(14)
(2–29)
(9)
(2–7)
(59)
(95)
(95)
(92)

Non-cases
(n 5 8)

5
44
1
22

(63)
(32–62)
(13)
(2–26)
0
2.16 (0.5–3)
4 (50)
6 (75)
7 (86)
1 (25)

RR

95% CI

P

0.9
NA
0.8
NA
Undefined
NA
1.1
2.3
1.5
3.3

0.3–2.5
NA
0.1–6.5
NA
Undefined
NA
0.7–1.7
0.5–11.7
0.4–6.1
1.1–20.2

NS
#0.05
NS
#0.05
NS
#0.05
NS
NS
NS
#0.05

* No cave explorers entering Cave A or Cave B used masks or reported immunocompromising conditions (including HIV/AIDS).
† RR 5 risk ratio; CI 5 confidence interval; NS 5 not significant; NA 5 not applicable. Risk ratios were not calculated for comparison of means.
‡ See schematic of Cave A (Figure 2).

age, fewer years of caving experience, and more hours spent
in the cave were all associated with acquiring acute histoplasmosis (p # 0.05). In Cave A, disease was associated
with crawling into or beyond a narrow tunnel (Figure 2). No
cave explorers reported using masks during the convention.
None of those cavers entering Caves A and B reported having a pre-existing illness or condition (diabetes, cancer, human immunodeficiency virus/AIDS or other immunocompromising condition) or receiving steroid therapy, which
might predispose them to acute histoplasmosis. The sex of
the caver was not found to be a risk factor for disease.
Skin test survey. Of the 228 Texas Caver’s Association
reunion participants, 113 (50%) participated in the separate
skin test survey. Of those, 68(60%) were skin test positive
(induration . 5 mm). Five (4%) of the 113 participants had
serologic evidence of recent infection with H. capsulatum
and symptoms consistent with acute histoplasmosis. Results
of a multivariate analysis of risk factors for infection are
shown in Table 2. Skin test reactivity was significantly associated with males (OR 5 1.5, 95% CI 5 1.1–2.5) and with
more years of caving experience (OR 5 1.8 per 10-year
increment, 95% CI 5 1.2–2.6). Of respondents, 68 (63%)
reported never having used a mask in their caving experience.

FIGURE 2. Schematic of Cave A showing the narrow tunnel associated with development of histoplasmosis among participants at
the National Speleological Society Convention. This is a lateral
view.

DISCUSSION

As we have shown, exposure to H. capsulatum during
caving may be associated with significant morbidity. A lack
of awareness of histoplasmosis among cavers may increase
the risk of infection and delay them seeking medical attention if symptoms develop. The continued reporting of caveassociated outbreaks suggests that current practice among
cavers continues to place them at risk for this potentially
serious infection. The data from our investigation suggest
that during the National Speleological Society Convention
in Brackettville, Texas, acute histoplasmosis was associated
with exposure to two caves. Findings from our cohort study
suggest that younger age and fewer years of caving experience may be risk factors for the development of acute histoplasmosis among cavers. These two variables are correlated, and only fewer years of caving experience remained independently associated with infection in multivariate analysis among the skin test survey participants. Multivariate
analysis was not performed in the cohort study of those entering Caves A and B. Also, in the cohort study, we found
that longer time spent in the caves was significantly associated with acquiring this infection. While this suggests a
dose response, it has been previously noted that histoplasmosis has developed in individuals whose sole exposure was
merely standing at the entrance to caves.4
As in other studies,1,6,15 diagnosis was delayed among
those convention attendees who developed illness. In addition, health care providers may fail to consider the diagnosis.
Although histoplasmosis is often a mild disease, delay in
diagnosis of severe cases may increase the likelihood of hospitalization and severe complications.1 This outbreak was detected by an astute clinician who noticed the correlation with
caving among a few of his patients. The fact that cave-associated epidemics are infrequently reported4 may be due to
a lack of recognition by physicians and a tendency toward
mild illness. However, because of increasing numbers of
cavers, histoplasmosis may become more common as a recreational disease. In addition, severity of symptomatic illness
may be related to intensity of exposure, and in this case,
both Caves A and B were heavily infested with bats. Entering a narrow tunnel in Cave A, which was approximately a
meter in diameter, was associated with acquiring histoplas-
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TABLE 2
Multivariate analysis of a risk factors for infection among participants in the skin-test survey, Texas Caver’s Association reunion*
Variable

Male sex (%)
Mean age (range)
Smoke (%)
Years caving, mean (range)
Hours caving previous year, mean (range)
History of histoplasmosis (%)
Live in endemic disease state†

Cases (n 5 71)

52
40
13
15
179
6
15

(73)
(18–57)
(18)
(0.1–38)
(0–2,000)
(8)

Controls (n 5 42)

22
35
7
9
64
1
6

(52)
(18–44)
(17)
(0.1–30)
(0–400)
(2)

OR

95% CI

P

1.5
0.9
1.2
1.8
3.1
1.4
1.4

1.1–2.5
0.8–1.1
0.4–3.4
1.2–2.6
0.5–8.9
0.4–1.9
0.5–5.2

#0.05
NS
NS
#0.05
NS
NS
NS

* OR 5 odds ratio; CI 5 confidence interval; NS 5 not significant.
† States along the Mississippi and Ohio River Valleys in the United States.

mosis. The tunnel was reported to be dry and dusty at the
time of the convention.
For histoplasmosis, certain risk factors predispose individuals to develop more serious disease. The likelihood of requiring hospitalization or of dying increases for a patient
with a pre-existing immunocompromising condition or therapy.16,17 Such risk factors are increasing among the United
States population in general because of an increase in the
use of immunocompromising medications and the spread of
the HIV epidemic. Although youth and inexperience were
found to be risk factors in our study, the numbers of cavers
reporting pre-existing conditions were insufficient to assess
differences in the occurrence of these conditions between
patients and controls. However, because this is a generally
healthy and active population, the high rate of disease found
in this outbreak is more likely to be due to intense exposure
in the caves.
The finding of 60% skin test positivity in the Texas Caving Association survey suggests that histoplasmosis is more
prevalent among cavers than the 31% rate previously reported in a national histoplasmin skin test survey of naval
recruits who gave their state of origin as Texas.18 Johnson
and others found a histoplasmin skin test sensitivity of 4.3%
for rural residents who lived near caves in Florida but a skin
test sensitivity of 64% among cavers from the same area.19
In South Africa, Murray and others reported a skin test positivity rate of 94.5% for cavers.20 Also, older cavers may be
more likely to have positive skin test reactions, reflecting
past exposure to H. capsulatum, and it is known that infection with H. capsulatum provides partial immunity to reinfection.15
Only 63% of cavers surveyed reported having ever used
a mask, and of all the cavers entering the high risk caves,
none used a mask. Although no studies have shown that
masks would prevent exposure during caving, the dust-mist
respirators now recommended for use in hospitals for tuberculosis control have the capacity to filter particles of 1–2
microns, which is the size of H. capsulatum spores.21 Preventive measures should be investigated to decrease the risk
of histoplasmosis among cave explorers, in particular, education of cavers and use of appropriate masks in caves. Specific control measures instituted following our investigation
included publishing a report of the caves involved in the
monthly newsletter of the National Speleological Association and posting warning signs at the caves. Routine culture
of soil samples from caves is not recommended because H.
capsulatum may be found in soil without an association with
disease. Decontamination of caves is not feasible or desir-

able because bat populations may be affected. To our knowledge, the effectiveness of chemoprophylaxis for cavers entering high-risk caves has not been studied. However, cavers
and their associations should expand their surveillance and
reporting systems, notify members about high-risk caves,
and educate young and recent members about the risks of
histoplasmosis associated with caving. Health care providers
should include questions regarding environmental exposure
to bird or bat guano, including caving, when interviewing
patients with symptoms of acute bronchitis or pneumonia
that may be compatible with histoplasmosis.
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